In developing countries, post-partum haemorrhage (PPH) and complications related to unsafe abortions are direct causes of maternal death. In Senegal, actions have been undertaken by the Government to reduce this burden and significant advances have been made in these areas in recent years. However, progress is still necessary to achieve the Millennium Development Goals (MDGs) for the reduction of the Maternal Mortality Rate (MMR) from 392 deaths per 100,000 live births in 2010–2011 to the target of 127 deaths per 100,000 live births by 2015. Misoprostol, a synthetic prostaglandin medicine, is recognized as essential for the management of PPH and for post-abortion care (PAC). The objective of the study was to understand the knowledge about, availability of and the practices in the provision of misoprostol at pharmacies in Dakar, Senegal, to ensure correct delivery of the product. The results will guide strategies for provision of misoprostol and for the reduction of maternal morbidity and mortality.
Ndao, R.; Mane, B.; Burke, E.; Diop, N.; Reiss, K.; Ngo, T.; Footman, K.; van Min, M. Knowledge and provision practices of misoprostol among pharmacies in Senegal. Marie Stopes International & PopulationCouncil, Dakar, Senegal (2014) 20 pp. [STEP UP Research Report]